Surgery in bronchial carcinoma with metastasis

Area of Science:

• Oncology
• Thoracic Surgery
• Cancer Metastasis Research

Background:

• Solitary M1 disease in lung cancer presents unique treatment challenges.
• Current literature often includes varied patient groups, potentially skewing survival data.
• The role of surgical resection in lung cancer with distant metastasis requires further clarification.

Purpose of the Study:

• To evaluate the outcomes of lung cancer patients undergoing resection for solitary M1 disease (brain or pleural metastasis).
• To compare survival rates in patients with solitary brain metastasis before primary tumor resection versus those with pleural disease.
• To determine the feasibility and benefit of surgical intervention in selected lung cancer patients with distant metastasis.

Main Methods:

• Retrospective analysis of two groups of lung cancer patients with solitary M1 disease.
• Group 1: Nine patients with solitary brain metastasis treated before or during primary lung tumor resection.
• Group 2: Eight patients with M1 disease, predominantly pleural metastasis.

Main Results:

• In the brain metastasis group, 6 patients died with an average survival of 10 months post-thoracotomy; 3 survived 15-31 months.
• Results for brain metastasis were less favorable than literature suggests, possibly due to study design differences.
• Patients with pleural disease showed improved quality of life and substantial survival (15-35 months), though risks remain.

Conclusions:

• Lung resection should be considered in selected lung cancer patients with solitary M1 disease, even with prior or concurrent metastasis.
• Adenocarcinoma and adenosquamous carcinoma were the most frequent histological types observed.
• Careful patient selection is crucial for optimizing outcomes in lung cancer surgery with metastasis.